Cavu Management, LP, 10% Owner at Lantern Pharma Inc. (LTRN), sold 290,696 shares at $3.44 ($1000K) on 2023-11-29, disclosed to the SEC on 2023-12-01.
Open-market sale of $1000k LTRN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.44 | 53,640 | $185K | 18.5% |
| 2 | $3.44 | 53,640 | $185K | 18.5% |
| 3 | $3.44 | 91,708 | $315K | 31.5% |
| 4 | $3.44 | 91,708 | $315K | 31.5% |
| Total | $3.44 avg | 290,696 | $1000K | 100% |
| Filing → |
| INAB | BUY | 2022-08-18 | $170K | — | Filing → |